NEW YORK (GenomeWeb News) – Life Technologies reported after the close of the market Wednesday that its second-quarter revenues declined 1 percent year over year, falling short of Wall Street estimates on the top line.

The Carlsbad, Calif.-based genetic analysis products firm reported total revenues of $945.8 million for the three months ended June 30, compared to $949.3 million for the second quarter of 2012. On average, analysts covering the firm expected revenues of $952.1 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: method to detect single-nucleotide and copy-number alterations in single cells from archival tissue, and more.

China has announced new rules governing the use of stem cell treatments, Nature News reports.

Wired's Sarah Zhang expresses frustration as a microbiome study of homes uncovers expected bacteria.

A database containing genome sequences from strains of foodborne pathogens may enable regulators and companies to quickly identify outbreak sources, Reuters reports.